David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.15% |
| 2 | Financials | 9.51% |
| 3 | Healthcare | 7.52% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 5.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
United Therapeutics
UTHR
$22.4B
| $7.71M | 0.01% |
36,800
-50,832
| -58% | -$11.4M |
|
1477
PUT
Macy's
M
$5.99B
| $7.7M | 0.01% |
491,200
-30,800
| -6% | -$546K |
|
1478
Allison Transmission
ALSN
$11B
| $7.69M | 0.01% |
227,807
-74,616
| -25% | -$2.79M |
|
|
PNTM
1479
DELISTED
Pontem Corporation
PNTM
| $7.68M | 0.01% |
772,764
+155,564
| +25% | +$1.54M |
|
|
AVB
1480
DELISTED
AvalonBay Communities
AVB
| $7.67M | 0.01% |
41,646
-8,389
| -17% | -$1.69M |
|
|
IGMS
1481
DELISTED
IGM Biosciences
IGMS
| $7.67M | 0.01% |
337,170
+62,616
| +23% | +$1.26M |
|
1482
Arista Networks
ANET
$248B
| $7.65M | 0.01% |
271,096
-1,141,060
| -81% | -$32.9M |
|
1483
LivaNova
LIVN
$4.32B
| $7.64M | 0.01% |
150,562
+71,014
| +89% | +$4.21M |
|
|
DCRD
1484
DELISTED
Decarbonization Plus Acquisition Corporation IV Class A Ordinary Share
DCRD
| $7.63M | 0.01% |
759,398
+352,336
| +87% | +$3.51M |
|
1485
Kodiak Sciences
KOD
$2.5B
| $7.62M | 0.01% |
985,069
+1,502
| +0.2% | +$14.6K |
|
|
NSTC
1486
DELISTED
Northern Star Investment Corp. III
NSTC
| $7.62M | 0.01% |
774,274
+47,900
| +7% | +$471K |
|
1487
Gibraltar Industries
ROCK
$1.38B
| $7.62M | 0.01% |
186,151
-76,288
| -29% | -$3.25M |
|
1488
PUT
SM Energy
SM
$8.57B
| $7.61M | 0.01% |
202,300
+142,000
| +235% | +$5.59M |
|
1489
Clarus
CLAR
$144M
| $7.6M | 0.01% |
564,545
-495,098
| -47% | -$9.64M |
|
|
EPWR
1490
DELISTED
Empowerment & Inclusion Capital I Corp.
EPWR
| $7.6M | 0.01% |
769,018
+110,200
| +17% | +$1.09M |
|
1491
CALL
Pembina Pipeline
PBA
$28.3B
| $7.59M | 0.01% |
250,000
-280,000
| -53% | -$9.99M |
|
1492
Wipro
WIT
$18.4B
| $7.59M | 0.01% |
3,221,242
+350,072
| +12% | +$905K |
|
|
HLAH
1493
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Class A Common Stock
HLAH
| $7.58M | 0.01% |
766,233
+200,000
| +35% | +$1.97M |
|
1494
CALL
CRISPR Therapeutics
CRSP
$5.73B
| $7.57M | 0.01% |
115,900
| – | – |
|
1495
Progressive
PGR
$130B
| $7.57M | 0.01% |
+65,168
| New | +$7.85M |
|
1496
PUT
Teladoc Health
TDOC
$1.14B
| $7.57M | 0.01% |
298,700
-590,000
| -66% | -$20.7M |
|
1497
AtriCure
ATRC
$2.42B
| $7.57M | 0.01% |
193,457
-20,533
| -10% | -$939K |
|
1498
Nasdaq
NDAQ
$55.4B
| $7.56M | 0.01% |
133,438
-223,436
| -63% | -$13.1M |
|
|
LCAA
1499
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
| $7.56M | 0.01% |
761,125
+54
| +0% | +$532 |
|
|
CERO
1500
DELISTED
CERo Therapeutics
CERO
| $7.55M | 0.01% |
374
+6
| +2% | +$121K |
|
Similar funds
David Shaw's Q3 2022 Portfolio in Review
As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
David Shaw withdrew a net $3.66B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, David Shaw opened a new position in Prologis worth $66.1M.
- David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
- David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- David Shaw opened 545 new positions and closed 678 in Q3 2022.
- David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.